SILVERARC CAPITAL MANAGEMENT, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q4 2021$935,000
-11.8%
66,812
+18.0%
0.38%
-36.7%
Q3 2021$1,060,000
-38.4%
56,614
-31.4%
0.60%
-22.0%
Q2 2021$1,722,000
-23.9%
82,573
+3.2%
0.77%
-37.8%
Q1 2021$2,262,000
-23.0%
80,000
-11.1%
1.23%
-27.7%
Q4 2020$2,939,00090,0001.71%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders